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Capital investment is an important factor to be considered when selecting a manufacturing strategy. For 
stainless steel facilities (chemical and biopharmaceutical), this is estimated often through the use of the “Lang” 
factor method. Cell therapy facilities present significantly distinct characteristics to traditional biopharma and 
chemical engineering facilities, including the use of expensive cleanrooms for open processing, the requirement 
for additional material storage space, and the reduced utility space and piping requirement. These factors call 
for the need of a dedicated method for estimating the capital investment and facility footprint of cell therapy 
facilities. This presentation proposes a method for the estimation of both these parameters. The method 
described here was developed at University College London, and recognizes that different technologies require 
different cleanroom classifications and have different equipment footprints. The footprint and area classification 
of each technology were used to estimate the facility building costs. Additional cost parameters considered in 
the capital investment calculation include: equipment, validation, commissioning and engineering costs. This 
method was used to calculate the facility costs and footprint in autologous and allogeneic scenarios, which were 
compared with the costs of existing cell therapy facilities. 
 
